14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 17 days ( 0 % )
Last Price $2.75 0 %
High/ Low $2.75 - $2.75 0%
Chg 7 Days N/A $2.75 $2.75
Chg 30 Days N/A $2.75 $2.75
Chg 12 mos -36.05 % $4.30 $2.75
Trend - 3 mos -9.38 % Width: 64.80 %
Trend - 12 mos -37.92 % Width: 143.97 %
Pred. range - 3 mos $1.84 - $3.02 -33.27 % - 10.00 %
Pred. range - 12 mos $1.11 - $2.72 -59.52 % - -1.24 %
Short MA avg 3 mos Buy Apr 10, 2018 - 41 days
Long MA avg 3 mos Buy May 07, 2018 - 22 days
Short/Long MA avg 3 mos Buy May 07, 2018 - 22 days
Short MA avg 12 mos Buy Apr 11, 2018 - 40 days
Long MA avg 12 mos Sell Jan 12, 2018 - 101 days
Short/Long MA avg 12 mos Sell Jan 25, 2018 - 92 days
Pivot Short Sell Jun 05, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Cogent Biosciences, Inc.

Cogent Biosciences. Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon ... COGT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT